Elanco Animal Health (NYSE:ELAN – Get Rating) updated its FY 2023 earnings guidance on Tuesday. The company provided EPS guidance of $0.76-$0.83 for the period, compared to the consensus EPS estimate of $0.78. The company issued revenue guidance of $4.31 billion-$4.40 billion, compared to the consensus revenue estimate of $4.33 billion. Elanco Animal Health also […]
Elanco Animal Health (NYSE:ELAN – Get Rating) issued an update on its second quarter 2023 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 0-$0.05 for the period, compared to the consensus estimate of $0.19. The company issued revenue guidance of $1.00 billion-$1.05 billion, compared to the consensus revenue estimate […]
Elanco Animal Health Incorporated (NYSE:ELAN – Get Rating) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 18,980,000 shares, a growth of 6.7% from the March 31st total of 17,790,000 shares. Based on an average daily volume of 7,760,000 shares, […]
AlphaCentric Advisors LLC raised its holdings in shares of Elanco Animal Health Incorporated (NYSE:ELAN – Get Rating) by 32.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 102,500 shares of the company’s stock after buying an additional 25,000 shares during the period. Elanco Animal […]
Pinnacle Wealth Management Advisory Group LLC decreased its position in Elanco Animal Health Incorporated (NYSE:ELAN – Get Rating) by 33.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 10,985 shares of the company’s stock after selling 5,500 shares during the period. Pinnacle Wealth Management […]